يعرض 1 - 10 نتائج من 11 نتيجة بحث عن '"T. Bachhuber"', وقت الاستعلام: 1.49s تنقيح النتائج
  1. 1
    Secukinumab 2‐weekly vs. 4‐weekly dosing in patients with plaque‐type psoriasis: results from the randomized GAIN study*

    المؤلفون: Ulrich Mrowietz, Kristian Reich, J Früh, Michael Sticherling, Christian Sieder, T. Bachhuber, Andreas Körber

    المصدر: British Journal of Dermatology. 184:849-856

    مصطلحات موضوعية: medicine.medical_specialty, Medizin, Dermatology, Antibodies, Monoclonal, Humanized, Severity of Illness Index, law.invention, 030207 dermatology & venereal diseases, 03 medical and health sciences, 0302 clinical medicine, Double-Blind Method, Randomized controlled trial, law, Psoriasis Area and Severity Index, Statistical significance, Internal medicine, Clinical endpoint, medicine, Humans, Psoriasis, Dosing, business.industry, Dermatology Life Quality Index, Confidence interval, Treatment Outcome, Quality of Life, Secukinumab, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22bfdfaa760908333d5040d9e05a81e0Test
    https://doi.org/10.1111/bjd.19398Test


    أضف إلى المفضلة
  2. 2
    Secukinumab treatment leads to normalization of quality of life and disease symptoms in psoriasis patients with or without prior systemic psoriasis therapy: the PROSE study results

    المؤلفون: Esteban Daudén, Aldo Cuccia, Jean-Luc Perrot, Piotr Jagiello, Ulrich Mrowietz, Matthias Augustin, Sven Gathmann, Roberto Orsenigo, Maria Polina Konstantinou, Christian Sieder, Sascha Gerdes, Külli Kingo, T. Bachhuber, Michael Rissler, Jacek C Szepietowski

    المصدر: Journal of the European Academy of Dermatology and Venereology. 35:431-440

    مصطلحات موضوعية: medicine.medical_specialty, Dermatology, Antibodies, Monoclonal, Humanized, Severity of Illness Index, Systemic therapy, 030207 dermatology & venereal diseases, 03 medical and health sciences, 0302 clinical medicine, Double-Blind Method, Psoriasis Area and Severity Index, Psoriasis, Internal medicine, Severity of illness, medicine, Humans, Prospective Studies, Prospective cohort study, business.industry, Antibodies, Monoclonal, Dermatology Life Quality Index, medicine.disease, Treatment Outcome, Infectious Diseases, 030220 oncology & carcinogenesis, Quality of Life, Itching, Secukinumab, medicine.symptom, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca631fcf7f65a9b99f00f5d67986859eTest
    https://doi.org/10.1111/jdv.16632Test


    أضف إلى المفضلة
  3. 3
    Secukinumab effects on disease burden, patient needs and benefits, and treatment satisfaction in patients with plaque psoriasis across European regions: patient perspective data from the PROSE study

    المؤلفون: N da Silva, Rachel Sommer, C.-E. Ortmann, Piotr Jagiello, T. Bachhuber, Matthias Augustin

    المصدر: Journal of the European Academy of Dermatology and Venereology : JEADVReferences. 35(11)

    مصطلحات موضوعية: medicine.medical_specialty, Dermatology, Personal Satisfaction, Antibodies, Monoclonal, Humanized, Severity of Illness Index, Quality of life, Cost of Illness, Double-Blind Method, Psoriasis Area and Severity Index, Psoriasis, Health care, Medicine, Humans, Clinical significance, Prospective Studies, Disease burden, business.industry, Dermatology Life Quality Index, medicine.disease, Infectious Diseases, Treatment Outcome, Patient Satisfaction, Physical therapy, Quality of Life, Secukinumab, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f534376113e2df2ce976bc3b61a6f75aTest
    https://pubmed.ncbi.nlm.nih.gov/34273904Test


    أضف إلى المفضلة
  4. 4
    Secukinumab is effective in treatment of moderate-to-severe plaque psoriasis : real-life effectiveness and safety from the PROSPECT study

    المؤلفون: Diamant Thaçi, E Duetting, Nima Melzer, R von Kiedrowski, Matthias Augustin, T. Kasparek, Andreas Körber, U. Amon, T. Bachhuber, G. Kraehn-Senftleben

    مصطلحات موضوعية: Adult, Male, Moderate to severe, medicine.medical_specialty, Medizin, Context (language use), Dermatology, Antibodies, Monoclonal, Humanized, Severity of Illness Index, 030207 dermatology & venereal diseases, 03 medical and health sciences, 0302 clinical medicine, Psoriasis Area and Severity Index, Psoriasis, Internal medicine, medicine, Humans, Prospective Studies, Plaque psoriasis, business.industry, Middle Aged, medicine.disease, Clinical trial, Treatment Outcome, Infectious Diseases, 030220 oncology & carcinogenesis, Concomitant, Secukinumab, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b34b764822179082b951b8a0ec3957bbTest
    https://www.ncbi.nlm.nih.gov/pubmed/31541554Test


    أضف إلى المفضلة
  5. 5
    26918 Describing real-world pediatric psoriasis patients in the US and EU5

    المؤلفون: Nadine Chapman-Rothe, Steve Lobosco, James Lucas, T. Bachhuber, Fetske Van Der Meulen, Amie Scott, James Piercy, Craig Richardson, Haijun Tian, James Hetherington, Sophie Meakin

    المصدر: Journal of the American Academy of Dermatology. 85:AB123

    مصطلحات موضوعية: medicine.medical_specialty, business.industry, Pediatric psoriasis, Medicine, Dermatology, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::d8bcb1572295a73b6fb7c0fea5cf424aTest
    https://doi.org/10.1016/j.jaad.2021.06.509Test


    أضف إلى المفضلة
  6. 6
    Secukinumab in pregnancy: outcomes in psoriasis, psoriatic arthritis and ankylosing spondylitis from the global safety database

    المؤلفون: Atul Deodhar, Weibin Bao, Jr J Safi, Dafna D. Gladman, E Altemeyer, Bruce Strober, Richard B. Warren, Kristian Reich, Sagair Hussain, Richard G. Langley, T Bachhuber

    المصدر: Warren, R B, Reich, K, Langley, R G, Strober, B, Gladman, D, Deodhar, A, Bachhuber, T, Bao, W, Altemeyer, E, Hussain, S & Safi, J 2018, ' Secukinumab in pregnancy : outcomes in psoriasis, psoriatic arthritis and ankylosing spondylitis from the global safety database ', The British journal of dermatology . https://doi.org/10.1111/bjd.16901Test

    مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, MEDLINE, Dermatology, Antibodies, Monoclonal, Humanized, 030207 dermatology & venereal diseases, 03 medical and health sciences, Psoriatic arthritis, 0302 clinical medicine, Pregnancy, Psoriasis, medicine, Adverse Drug Reaction Reporting Systems, Humans, Spondylitis, Ankylosing, Spondylitis, 030203 arthritis & rheumatology, Ankylosing spondylitis, business.industry, Pregnancy Outcome, Antibodies, Monoclonal, medicine.disease, Pregnancy Complications, Pregnancy Trimester, First, Maternal Exposure, Paternal Exposure, Monoclonal, Female, Secukinumab, business, Follow-Up Studies

    وصف الملف: application/pdf

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c247369ad27c591d00a4699c6afa0a73Test
    https://doi.org/10.1111/bjd.16901Test


    أضف إلى المفضلة
  7. 7
    Secukinumab treatment of moderate to severe plaque psoriasis in routine clinical care : Real-life data of prior and concomitant use of psoriasis treatments from the PROSPECT study

    المؤلفون: Nima Melzer, Diamant Thaçi, Andreas Körber, U. Amon, T. Bachhuber, R von Kiedrowski, Matthias Augustin, G. Kraehn-Senftleben, T. Kasparek

    مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Medizin, Dermatology, Antibodies, Monoclonal, Humanized, Severity of Illness Index, 030207 dermatology & venereal diseases, 03 medical and health sciences, 0302 clinical medicine, Psoriasis Area and Severity Index, Germany, Psoriasis, Internal medicine, Severity of illness, medicine, Humans, Prospective Studies, Adverse effect, Retrospective Studies, business.industry, Antibodies, Monoclonal, Middle Aged, medicine.disease, Interim analysis, Surgery, Discontinuation, Treatment Outcome, Infectious Diseases, Withholding Treatment, 030220 oncology & carcinogenesis, Concomitant, Drug Therapy, Combination, Female, Secukinumab, Dermatologic Agents, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd63b045be265a13ae049337660ac52aTest
    https://www.ncbi.nlm.nih.gov/pubmed/28960469Test


    أضف إلى المفضلة
  8. 8
    A matter of perspective: Imputation methods and their effects illustrated with the use of data from the PRIME study

    المؤلفون: T. Bachhuber, Christian Sieder, Michael Sticherling, Kristian Reich, Nima Melzer

    المصدر: Journal of the American Academy of Dermatology. 79:AB13

    مصطلحات موضوعية: business.industry, Econometrics, Medicine, Dermatology, Imputation (statistics), business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::d910ab2a326695d171a9cc7e598d3c72Test
    https://doi.org/10.1016/j.jaad.2018.05.098Test


    أضف إلى المفضلة
  9. 9
    From relative to absolute treatment outcomes—Correlation of PASI 90 and PASI ≤2 in three clinical trials with secukinumab

    المؤلفون: Nima Melzer, Kristian Reich, Christian Sieder, Michael Sticherling, T. Bachhuber

    المصدر: Journal of the American Academy of Dermatology. 79:AB143

    مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, business.industry, Treatment outcome, Dermatology, Correlation, Clinical trial, 030207 dermatology & venereal diseases, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Internal medicine, Medicine, Secukinumab, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::54344b7a7cf9adcebbaa7eee7d191d8aTest
    https://doi.org/10.1016/j.jaad.2018.05.594Test


    أضف إلى المفضلة
  10. 10
    009 PASI ≤ 2 corresponds to PASI 90, irrespective of baseline severity: A post-hoc analysis of the PRIME-study

    المؤلفون: T. Bachhuber, Christian Sieder, Nima Melzer, Michael Sticherling, Kristian Reich

    المصدر: Journal of Investigative Dermatology. 137:S194

    مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, business.industry, Cell Biology, Dermatology, Biochemistry, Prime (order theory), 03 medical and health sciences, 030104 developmental biology, Post-hoc analysis, Physical therapy, medicine, Baseline (configuration management), business, Molecular Biology

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::0e35776204ec69a4320290718f2589f3Test
    https://doi.org/10.1016/j.jid.2017.07.105Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث